In your state, you are required to confirm you wish to access this information. Please enter 'QLD' or 'WA' in the field below to continue.

No thanks

Faulty High-tech braking systems: Subaru and Honda Recalls

car-open-road

The safety of cars with automatic braking systems have been called into question with car manufactures issuing worldwide recalls in response to faulty program software. Car manufactures Subaru and Honda have announced large recalls due to malfunctioning technology designed to prevent rear-end crashes and avoid hitting pedestrians, yet instead are putting the vehicles at risk of collision.

Subaru has announced recalls of more than 5000 of its latest Outback wagon and Liberty sedan models equipped with Pre-Collisions Braking and Adaptive Cruise Control, due to a software programming issue.

According to the Australian Competition and Consumer Commission, in the event of a brake lamp switch failure in an affected vehicle, the pre-collision breaking system may not operate properly in an emergency braking situation, or may fail to adequately engage the brakes, potentially leading to an accident. Subaru ensures, however, that this defect does not affect the performance of the brakes when engaged by the driver.

Honda Australia is recalling more than 2000 of its latest Accord sedan 2013- 2015 and CR-V 2013- 2015 models, equipped with similar automotive emergency braking technology. The problem first surfaced in Japan in November of 2013 when an SUV braked for no reason and caused a rear-end collision. While Honda was investigating the matter, another incident occurred in June last year.

“In certain driving conditions, the Collision Mitigation Braking System may unexpectedly activate while operating the vehicle,” the Honda recall statement says.

Furthermore, Acura, the luxury vehicle division of Honda, has also been forced to recall two models due to the same malfunction. The recall involves just under 48,000 MDX SUVs and RLX sedans from the 2012 and 2015 model years.

Subaru and Honda are not the only car manufacturers facing issues with autonomous braking systems. The National Highway Traffic Safety Administration in America commenced investigations into the 2014 Jeep Grand Cherokee braking systems, which have been alleged as also containing auto-brake system issues.

No accidents that have been attributed to failures of these automatic braking system have been reported in Australia.

 

Click to read about Product Liability claims

Written by Shine Lawyers on . Last modified: September 21, 2017.

Join the discussion

Share this article:

There are 0 comments. Be the first!

China-Australia Free Trade Agreement: potential commercial implications

The China-Australia Free Trade Agreement (ChAFTA) was signed on the 17th June 2015, implementing a foundation in the next phase of inter-economic relationships between Australia and China. The potential for the ChAFTA to create opportunities for Australia is evident, with China accounting for Australia’s largest export market for goods and services and a nearly a […]

Read more

Breast implant suspended from Australian market

The Therapeutic Goods Association (TGA) has imposed a 6 month suspension on Cereform silicone gel-filled breast implants and associated sizers from the Australian Register of Therapeutic Goods. Since 2009, about 4800 of the implants were sold in Australia. The action taken by the TGA will now prevent the devices from being supplied to the Australian […]

Read more

Blood thinner Xarelto linked to potentially fatal bleeding

Clinical trials and post-market experience have linked widely used blood-thinning drug Xarelto and similar anticoagulants to incidences of major bleeding, some of which have been fatal. Xarelto works to reduce the tendency of blood to form clots and may be prescribed to prevent or treat blood clots in the brain, lungs, legs, or veins. Patients […]

Read more

Blood thinner to face action over fatal bleeding

A new blood thinning agent, marketed for having minimal side effects, may face litigation in the U.S. involving claims the medication has been linked to potentially fatal bleeding complications. Eliquis (Apixaban) is an anti-clotting agent used for persons with a heart irregularity known as atrial fibrillation to reduce risk of stroke. It is also used […]

Read more

Call Us Now

Our friendly consultants are available to talk Monday to Friday, 8:15am to 6:00pm AEST.

1800 618 851

Live Chat

Chat with Shine Lawyers through the livechat system without leaving your computer. No downloading, completely private and best of all - its easy to use.

Start a live chat now

Enquire Now

Enquire now